How many institutions held IMVT - Immunovant, Inc. - Common Stock, par value $0.0001 per share in Q2 2023?

145 institutional investors reported IMVT - Immunovant, Inc. - Common Stock, par value $0.0001 per share for Q2 2023. Use the holders table for investor-level position and value details.

Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT)

Q: What does CUSIP 45258J102 represent in this 13F holders report?

CUSIP 45258J102 is the security identifier for IMVT - Immunovant, Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

CUSIP: 45258J102

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class: Equity / Common Stock, par value $0.0001 per share
Shares outstanding: 202,731,676
Total 13F shares: 55,460,743
Share change: -2,941,813
Total reported value: $1,051,890,599
Put/Call ratio: 74%
Price per share: $18.97
Number of holders: 145
Value change: -$33,129,073
Number of buys: 82
Number of sells: 69

Quarterly Holders Quick Answers

What is CUSIP 45258J102?
CUSIP 45258J102 identifies IMVT - Immunovant, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2023
Previous quarter: Q1 2023

Recent filing periods for CUSIP 45258J102:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of IMVT - Immunovant, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Deep Track Capital, LP	13F	Company	3.7%	7,432,717	$115,281,441	—	31 Mar 2023	13F
VANGUARD GROUP INC	13F	Company	2.5%	5,143,709	$79,778,926	—	31 Mar 2023	13F
FMR LLC	13F	Company	2%	4,146,969	$64,319,490	—	31 Mar 2023	13F
STATE STREET CORP	13F	Company	2%	3,967,605	$61,537,554	—	31 Mar 2023	13F
BlackRock Finance, Inc.	13F	Company	1.9%	3,937,181	$61,065,677	—	31 Mar 2023	13F
BVF INC/IL	13F	Company	1.3%	2,561,000	$39,721,110	—	31 Mar 2023	13F
Logos Global Management LP	13F	Company	1.2%	2,500,000	$38,775,000	—	31 Mar 2023	13F
Commodore Capital LP	13F	Company	0.71%	1,440,999	$22,349,894	—	31 Mar 2023	13F
Alpine Global Management, LLC	13F	Company	0.71%	1,439,544	$22,327,327	—	31 Mar 2023	13F
EVENTIDE ASSET MANAGEMENT, LLC	13F	Company	0.69%	1,390,000	$21,558,900	—	31 Mar 2023	13F
Redmile Group, LLC	13F	Company	0.65%	1,317,031	$20,427,151	—	31 Mar 2023	13F
PERCEPTIVE ADVISORS LLC	13F	Company	0.64%	1,291,858	$20,036,718	—	31 Mar 2023	13F
COWEN AND COMPANY, LLC	13F	Company	0.62%	1,250,000	$19,387,500	—	31 Mar 2023	13F
CITADEL ADVISORS LLC	13F	Company	0.58%	1,165,876	$18,082,737	—	31 Mar 2023	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.53%	1,082,902	$16,796,000	—	31 Mar 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.52%	1,048,718	$16,265,621	—	31 Mar 2023	13F
Avidity Partners Management LP	13F	Company	0.51%	1,043,000	$16,176,930	—	31 Mar 2023	13F
DIMENSIONAL FUND ADVISORS LP	13F	Company	0.51%	1,031,963	$16,005,649	—	31 Mar 2023	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.48%	972,870	$15,089,214	—	31 Mar 2023	13F
TWO SIGMA ADVISERS, LP	13F	Company	0.41%	840,100	$13,029,951	—	31 Mar 2023	13F
Ikarian Capital, LLC	13F	Company	0.38%	774,398	$12,010,913	—	31 Mar 2023	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	0.33%	665,785	$10,326,325	—	31 Mar 2023	13F
TCG Crossover Management, LLC	13F	Company	0.32%	654,853	$10,156,770	—	31 Mar 2023	13F
Frazier Life Sciences Management, L.P.	13F	Company	0.29%	585,759	$9,085,122	—	31 Mar 2023	13F
Polar Asset Management Partners Inc.	13F	Company	0.26%	528,000	$8,189,280	—	31 Mar 2023	13F
Nuveen Asset Management, LLC	13F	Company	0.26%	522,396	$8,102,000	—	31 Mar 2023	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.24%	492,112	$7,633,000	—	31 Mar 2023	13F
PFM Health Sciences, LP	13F	Company	0.23%	462,431	$7,172,305	—	31 Mar 2023	13F
D. E. Shaw & Co., Inc.	13F	Company	0.22%	444,453	$6,893,466	—	31 Mar 2023	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.22%	443,204	$6,875,000	—	31 Mar 2023	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.22%	440,858	$6,837,708	—	31 Mar 2023	13F
NORTHERN TRUST CORP	13F	Company	0.2%	411,047	$6,375,339	—	31 Mar 2023	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.2%	409,814	$6,356,216	—	31 Mar 2023	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.19%	388,467	$6,025,123	—	31 Mar 2023	13F
VOLORIDGE INVESTMENT MANAGEMENT, LLC	13F	Company	0.19%	387,317	$6,007,287	—	31 Mar 2023	13F
PLATINUM INVESTMENT MANAGEMENT LTD	13F	Company	0.17%	346,970	$5,381,505	—	31 Mar 2023	13F
Rafferty Asset Management, LLC	13F	Company	0.16%	327,916	$5,085,977	—	31 Mar 2023	13F
CITIGROUP INC	13F	Company	0.14%	285,367	$4,426,042	—	31 Mar 2023	13F
Hillsdale Investment Management Inc.	13F	Company	0.13%	262,100	$4,065,171	—	31 Mar 2023	13F
Hennion & Walsh Asset Management, Inc.	13F	Company	0.11%	227,556	$3,529,000	—	31 Mar 2023	13F
MORGAN STANLEY	13F	Company	0.11%	227,091	$3,522,182	—	31 Mar 2023	13F
Parkman Healthcare Partners LLC	13F	Company	0.09%	186,045	$2,885,558	—	31 Mar 2023	13F
Bank of New York Mellon Corp	13F	Company	0.08%	169,074	$2,622,338	—	31 Mar 2023	13F
HighVista Strategies LLC	13F	Company	0.08%	163,799	$2,540,522	—	31 Mar 2023	13F
Weiss Multi-Strategy Advisers LLC	13F	Company	0.08%	162,426	$2,519,000	—	31 Mar 2023	13F
Cubist Systematic Strategies, LLC	13F	Company	0.08%	153,819	$2,385,726	—	31 Mar 2023	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.07%	142,029	$2,202,870	—	31 Mar 2023	13F
BOOTHBAY FUND MANAGEMENT, LLC	13F	Company	0.07%	138,000	$2,140,380	—	31 Mar 2023	13F
Woodline Partners LP	13F	Company	0.07%	137,592	$2,134,052	—	31 Mar 2023	13F
PRUDENTIAL FINANCIAL INC	13F	Company	0.06%	123,630	$1,917,501	—	31 Mar 2023	13F

Institutional Holders of Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) as of Q2 2023

As of 30 Jun 2023, Immunovant, Inc. - Common Stock, par value $0.0001 per share (IMVT) was held by 145 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 55,460,743 shares. The largest 10 holders included VANGUARD GROUP INC, Deep Track Capital, LP, FMR LLC, BlackRock Inc., STATE STREET CORP, PERCEPTIVE ADVISORS LLC, Logos Global Management LP, Avidity Partners Management LP, Redmile Group, LLC, and Alpine Global Management, LLC. This page lists 145 institutional shareholders reporting positions in this security for the Q2 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders

140

Q2 2023 holders

145

Holder diff

Investor	Q1 2023 Shares	Q2 2023 Shares	Share Diff	Share Chg %	Q1 2023 Value $	Q2 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.